Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 11083876)

Published in J Biol Chem on November 16, 2000

Authors

S Frantz1, R A Kelly, T Bourcier

Author Affiliations

1: Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Articles citing this

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest (2005) 3.48

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res (2011) 2.99

Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol (2011) 2.40

Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol (2008) 1.95

Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol (2003) 1.79

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res (2011) 1.64

An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol (2010) 1.64

Toll receptors: a central element in innate immune responses. Infect Immun (2002) 1.53

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol (2010) 1.41

Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol (2008) 1.35

Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol (2007) 1.30

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol (2010) 1.25

Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol (2015) 1.22

Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction. Br J Pharmacol (2003) 1.20

Molecular events in the cardiomyopathy of sepsis. Mol Med (2008) 1.18

TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem (2011) 1.18

NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol (2007) 1.16

NOX enzymes and Toll-like receptor signaling. Semin Immunopathol (2008) 1.13

Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production. J Biol Chem (2010) 1.12

Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res (2015) 1.05

Mechanisms and management of doxorubicin cardiotoxicity. Herz (2011) 1.05

Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol (2007) 1.04

Toll-like receptors and myocardial inflammation. Int J Inflam (2011) 1.03

Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS One (2010) 1.02

Innate immunity and cardiomyocytes in ischemic heart disease. Life Sci (2014) 1.02

Pathogenesis of Chagas disease: time to move on. Front Biosci (Elite Ed) (2012) 1.01

Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infect Immun (2003) 1.00

Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun (2005) 0.99

The multiple facets of toll-like receptors in transplantation biology. Transplantation (2008) 0.99

Innate immunity and remodelling. Heart Fail Rev (2011) 0.98

Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med (2008) 0.97

Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. Am J Physiol Heart Circ Physiol (2010) 0.97

The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system. Infect Immun (2003) 0.94

Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2010) 0.94

Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One (2012) 0.94

Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol (2005) 0.91

Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp Biol Med (Maywood) (2009) 0.91

Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cells. Infect Immun (2006) 0.90

Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia. Cardiol Res Pract (2012) 0.89

Therapeutic targeting of innate immunity in the failing heart. J Mol Cell Cardiol (2010) 0.89

Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc (2010) 0.87

Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence. Antioxid Redox Signal (2013) 0.86

Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol (2012) 0.85

Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation. Int J Endocrinol (2014) 0.85

Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells. Mol Med (2008) 0.83

Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis. Mediators Inflamm (2013) 0.83

Toll-like receptor 4-mediated nuclear factor kappa B activation is essential for sensing exogenous oxidants to propagate and maintain oxidative/nitrosative cellular stress. PLoS One (2013) 0.82

TLR2, TLR3, and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells. Cell Stress Chaperones (2013) 0.81

Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection. Med Microbiol Immunol (2011) 0.80

Toll-like receptors expression in follicular cells of patients with poor ovarian response. Int J Fertil Steril (2014) 0.80

Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression. World J Gastroenterol (2005) 0.79

Role of nitric oxide in Toll-like receptor 2 and 4 mRNA expression in liver of acute hemorrhagic necrotizing pancreatitis rats. World J Gastroenterol (2006) 0.79

GSK-3beta inhibitor modulates TLR2/NF-kappaB signaling following myocardial ischemia-reperfusion. Inflamm Res (2009) 0.77

The Effect of Estradiol and Progesterone on Toll Like Receptor Gene Expression in A Human Fallopian Tube Epithelial Cell Line. Cell J (2016) 0.76

The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease. J Immunol Res (2016) 0.76

TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice. Am J Physiol Lung Cell Mol Physiol (2016) 0.76

Articles by these authors

(truncated to the top 100)

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest (2000) 4.79

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest (1999) 2.94

Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem (1996) 2.82

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A (1997) 2.56

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem (1998) 2.42

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A (1993) 2.32

Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest (1999) 2.13

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol (1999) 2.07

Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res (1999) 1.81

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem (1995) 1.80

Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest (1986) 1.78

Calcium and proton activities in rat cardiac mitochondria. Effect of matrix environment on behaviour of fluorescent probes. Biochem J (1989) 1.60

Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest (1987) 1.60

In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. J Cardiovasc Electrophysiol (2001) 1.56

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest (1993) 1.54

Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation (2001) 1.51

Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem (1994) 1.49

Digitalis. Circulation (1999) 1.43

Continual electric field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am J Physiol (1994) 1.41

NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am J Physiol (1999) 1.37

Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem (1997) 1.33

Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res (1999) 1.31

Cytokines and cardiac contractile function. Circulation (1997) 1.29

Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na(+)-H+ exchanger. Circ Res (1991) 1.26

Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function. Am J Physiol (1993) 1.26

Systemic response to thermal injury in rats. Accelerated protein degradation and altered glucose utilization in muscle. J Clin Invest (1984) 1.25

Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem (1998) 1.24

An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol (1999) 1.24

Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 1.23

Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol (1993) 1.22

Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem (1996) 1.20

Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest (1996) 1.18

An intrinsic adrenergic system in mammalian heart. J Clin Invest (1996) 1.17

Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci U S A (1996) 1.15

Role of epicardial mesothelial cells in the modification of phenotype and function of adult rat ventricular myocytes in primary coculture. Circ Res (1992) 1.15

Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med (1983) 1.14

In situ calibration of fura-2 and BCECF fluorescence in adult rat ventricular myocytes. Am J Physiol (1990) 1.14

Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells. Circ Res (1996) 1.14

Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent. Circulation (1990) 1.12

Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ Res (1999) 1.11

Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J (2000) 1.10

Comparison of PCR, microscopic examination and culture for the early diagnosis and characterization of Acanthamoeba isolates from ocular infections. Eur J Clin Microbiol Infect Dis (2007) 1.09

Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species. J Biol Chem (1999) 1.08

The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res (2001) 1.06

Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem (1996) 1.05

Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol (1995) 1.02

Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem (1986) 0.99

Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am J Physiol (1995) 0.99

Transcriptional regulation in cardiac muscle. Coordinate expression of Id with a neonatal phenotype during development and following a hypertrophic stimulus in adult rat ventricular myocytes in vitro. J Biol Chem (1992) 0.95

Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies. J Biol Chem (1985) 0.94

Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am J Physiol (1998) 0.93

Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes. Circ Res (1999) 0.93

Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem (1996) 0.92

Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem (1995) 0.91

Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes. J Clin Invest (1996) 0.91

Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res (1996) 0.91

Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int (1987) 0.91

Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther (2007) 0.91

Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase. J Mol Cell Cardiol (2000) 0.91

Correlation between tear IgE levels and HLA-DR expression by conjunctival cells in allergic and nonallergic chronic conjunctivitis. Graefes Arch Clin Exp Ophthalmol (2000) 0.90

Activation of cardiac c-Jun NH(2)-terminal kinases and p38-mitogen-activated protein kinases with abrupt changes in hemodynamic load. Hypertension (2001) 0.89

Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sci (1999) 0.89

Posttranscriptional regulation of Id1 activity in cardiac muscle. Alternative splicing of novel Id1 transcript permits homodimerization. J Biol Chem (1994) 0.89

S-nitrosothiols inhibit neuronal norepinephrine transport. Am J Physiol (1997) 0.89

Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J Biol Chem (1994) 0.88

Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. Am J Physiol (1987) 0.88

Regulation of bFGF expression and ANG II secretion in cardiac myocytes and microvascular endothelial cells. Am J Physiol (1997) 0.88

[Cornea guttata and Fuchs' dystrophy]. J Fr Ophtalmol (1999) 0.87

Outcome of Corneal transplantation rejection. Cornea (2001) 0.87

Response of the kidney to furosemide. II. Effect of captopril on sodium balance. Kidney Int (1983) 0.87

Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. J Biol Chem (1997) 0.87

Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res (1995) 0.86

Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis. Br J Ophthalmol (2006) 0.85

Abnormal cation transport in uremia. Mechanisms in adipocytes and skeletal muscle from uremic rats. J Clin Invest (1988) 0.85

The genotypic characterisation of Acanthamoeba isolates from human ocular samples. Br J Ophthalmol (2008) 0.84

Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol (1994) 0.84

Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res (1995) 0.84

Use of digital camera imaging of eye fundus for telemedicine in children suspected of abusive head injury. Br J Ophthalmol (2008) 0.84

Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J Clin Invest (1993) 0.84

[Study and prevention of contact lens-related microbial keratitis with a standardized questionnaire]. J Fr Ophtalmol (2010) 0.83

Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2001) 0.83

Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. J Mol Cell Cardiol (1998) 0.83

The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes. Ann N Y Acad Sci (1999) 0.83

Cutaneous necrosis caused by systemically administered heparin. JAMA (1981) 0.83

Familial pseudotumoral sclerochoroidal calcification associated with chondrocalcinosis. Br J Ophthalmol (2004) 0.83

Tissue crossmatch before corneal transplantation. Br J Ophthalmol (2004) 0.82

Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int (1987) 0.82

Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol (1998) 0.82

Activation of nitric oxide synthase (NOS3) by mechanical activity alters contractile activity in a Ca2+-independent manner in cardiac myocytes: role of troponin I phosphorylation. Biochem Biophys Res Commun (1999) 0.82

Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. Circulation (2001) 0.82

[Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases]. J Fr Ophtalmol (2002) 0.81

[Diplopia complicating scleral buckling surgery for retinal detachment]. J Fr Ophtalmol (2007) 0.81

Endothelins. Myocardial actions of a new class of cytokines. Circulation (1992) 0.80

[Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis]. J Fr Ophtalmol (2010) 0.80

The role of the NO pathway in the control of cardiac function. J Card Fail (1996) 0.80

[Acute closure-angle glaucoma after treatment with ipratropium bromide and salbutamol aerosols]. J Fr Ophtalmol (2000) 0.80

Role of nitric oxide in ventricular dysfunction. J Card Fail (1998) 0.80

Nitric oxide regulation of atrioventricular node excitability. Can J Cardiol (1997) 0.79

[Infectious keratitis after penetrating keratoplasty]. J Fr Ophtalmol (2001) 0.79

Expression and regulation of the sodium-calcium exchanger in cardiac microvascular endothelial cells. Clin Exp Pharmacol Physiol (1999) 0.79